Key Takeaways
- • TPG is exploring a sale of Lyric, a healthcare software company, at a potential $5 billion valuation, signaling potential liquidity events in the software sector among major PE players.
- • Blue Owl Capital is in early-stage exploration of launching a real estate investment trust (REIT), reflecting continued institutional appetite for structured real estate exposure.
- • CVC Capital Partners is considering divesting personal care company Arthea at an estimated $2 billion valuation, indicating active portfolio optimization across European and global PE platforms.
Summary
Three major alternative asset managers are in exploratory phases on separate transactions, according to market intelligence from September 10, 2026. TPG, one of the largest global private equity firms, may be considering a sale of Lyric, a healthcare software platform in its portfolio, with the transaction potentially valuing the company at $5 billion. The move reflects ongoing portfolio management and monetization strategies among mega-cap PE firms as software valuations stabilize in the mid-market.
Separately, Blue Owl Capital is exploring the structural launch of a real estate investment trust, a vehicle that would provide institutional and retail investors with REIT-level access to the firm's real estate investment platform. This initiative underscores Blue Owl's focus on diversifying capital deployment across real assets and liquidity structures following its 2022 merger with Dyal Capital Partners.
Additionally, CVC Capital Partners is evaluating a potential exit of Arthea, a personal care company within its portfolio, at an estimated $2 billion valuation. The transaction would represent another example of active portfolio pruning and capital redeployment by large European PE platforms. These parallel transactions across multiple tier-one sponsors suggest consistent market appetite for both healthcare software and consumer-oriented business exits in the current environment.
Separately, Blue Owl Capital is exploring the structural launch of a real estate investment trust, a vehicle that would provide institutional and retail investors with REIT-level access to the firm's real estate investment platform. This initiative underscores Blue Owl's focus on diversifying capital deployment across real assets and liquidity structures following its 2022 merger with Dyal Capital Partners.
Additionally, CVC Capital Partners is evaluating a potential exit of Arthea, a personal care company within its portfolio, at an estimated $2 billion valuation. The transaction would represent another example of active portfolio pruning and capital redeployment by large European PE platforms. These parallel transactions across multiple tier-one sponsors suggest consistent market appetite for both healthcare software and consumer-oriented business exits in the current environment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.